Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

433989

registered interest
date	03/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to raise public awareness of multiple myeloma and the risks presented by late diagnosis of acute myeloid leukaemia.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	18669
answer	answer is ministerial correction date of answer 11/12/2015 answer text <p>Public Health England’s ‘Be Clear on Cancer’ campaigns do not currently include multiple myeloma.</p><br /><p>A number of factors are taken into account when deciding which campaigns to develop and run, with one of the main criteria being the scope to save lives through earlier diagnosis and whether the cancer has a clear early sign or symptom that the general public can act upon should it arise.</p><br /><p>We appreciate that this means that there are a number of cancers, besides Myeloid Leukaemia, that are not covered by ‘Be Clear on Cancer’ specifically. Given this, Public Health England is looking at developing an approach to raise awareness of generic symptoms that can indicate a wider number of cancers and the need to visit the doctor promptly with these symptoms. This work is currently in development, with the help of a number of experts, including clinicians and charities.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 11/12/2015 11:47:28 answering member 3918 label Biography information for Jane Ellison
tabling member	3960 label Biography information for Henry Smith

433998

registered interest
date	03/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Multiple Myeloma
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether an assessment has been made of the barriers preventing multiple myeloma patients accessing the most innovative treatments.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	18708
answer	answer is ministerial correction date of answer 11/12/2015 answer text <p>No specific assessment has been made of the barriers affecting access to the most innovative treatments for patients with multiple myeloma.</p><br /><p>It is essential that a robust process is in place to ensure that patients get rapid access to the most innovative drugs that represent value for money to the National Health Service. The Cancer Drugs Fund has helped over 84,000 people to access the life-extending drugs they need, and NHS England and the National Institute for Health and Care Excellence are currently consulting on the future shape of the Fund to put it on a more sustainable footing.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 11/12/2015 12:18:24 answering member 3918 label Biography information for Jane Ellison
tabling member	3960 label Biography information for Henry Smith